Back to Search
Start Over
Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).
- Source :
-
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2024 Sep; Vol. 56 (9), pp. 1544-1550. Date of Electronic Publication: 2024 Mar 29. - Publication Year :
- 2024
-
Abstract
- TIPS is the most effective treatment for portal hypertension. Patient selection remains important to achieving optimal post-TIPS outcomes. The study evaluates 1-year mortality factors in cirrhotic patients receiving TIPS.<br />Methods: 87 cirrhotic patients received a TIPS between 2015 - 2021. Predictors of 1-year and overall mortality were assessed by estimating cumulative incidence functions and Grey's test to adjust for liver transplantation as a risk competing with mortality. Variables with p < 0.05 were checked for collinearity and included in the multivariate Cox proportional hazards model. Model discrimination was evaluated by calculating the area under the ROC curve.<br />Results: 87 patients were included (68% men; 22% ≥70 years). ALD was the primary cirrhosis cause. Most patients were Child-Pugh class B, MELD-Na score was 13.6 ± 6.0 points. The most frequent indication for TIPS was bleeding (51.7%), followed by refractory ascites (42.5%). The variables positively associated with mortality in univariate analysis were ascites, clinically overt sarcopenia and MELD-Na score, while ongoing nutritional supplementation improved survival. In the multivariate analysis, only clinically overt sarcopenia and MELD-Na score remained independently associated with mortality. A MELD-Na/sarcopenia model demonstrated a good discrimination, AUROC: 0.86 (95% CI 0.77 - 0.95).<br />Conclusion: MELD-Na score, and sarcopenia were significantly associated with 1-year survival in cirrhotic patients who received TIPS.<br />Competing Interests: Conflict of Interest The authors declare that there are not conflicts of interest regarding the manuscript “Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts Mortality after transjugular intrahepatic portosystemic shunt (TIPS)”. The authors have no financial, personal or professional affiliations that could influence or bias the content and findings presented in this manuscript.<br /> (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Subjects :
- Humans
Male
Female
Middle Aged
Aged
Retrospective Studies
End Stage Liver Disease surgery
End Stage Liver Disease mortality
End Stage Liver Disease complications
Severity of Illness Index
Hypertension, Portal mortality
Proportional Hazards Models
ROC Curve
Ascites etiology
Ascites mortality
Adult
Multivariate Analysis
Sarcopenia complications
Sarcopenia mortality
Portasystemic Shunt, Transjugular Intrahepatic adverse effects
Liver Cirrhosis complications
Liver Cirrhosis mortality
Liver Cirrhosis surgery
Subjects
Details
- Language :
- English
- ISSN :
- 1878-3562
- Volume :
- 56
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
- Publication Type :
- Academic Journal
- Accession number :
- 38555198
- Full Text :
- https://doi.org/10.1016/j.dld.2024.03.003